Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design

Critical Care

Volumn 6, Issue 5, 2002, Pages 394-396

  Honoré, Patrick M ^a   Matson, James R ^b  

^a Clinique Saint Pierre of Ottignies   (Belgium)

^b MEDICAL CITY DALLAS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MEMBRANE PROTEIN;

ARTICLE; BLOOD FILTRATION; CONTROLLED STUDY; FILTER DESIGN; HEMADSORPTION; HEMOFILTRATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; MEMBRANE FILTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RAT; SEPSIS; SURVIVAL RATE; ULTRAFILTRATION;

EID: 0036789027     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1826     Document Type: Article

References (24)

1. Kellum JA, Dishart MK: Effects of hemofiltration on circulating IL-6 levels in septic rats. Crit Care Forum 2002, 6:429-433.
2. Lonnemann G, Koch K, Shaldon S, Dinarello C: Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1. J Lab Clin Med 1988, 112:76-86.
3. Goldfarb S, Golper T: Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 1994, 5:228-232.
4. Birk H-W, Kistner A, Wizemann V, Schutterle G: Protein adsorption by artificial membrane materials under filtration conditions. Artificial Organs 1995, 19:411-415.
5. Saksena S, Zydney A: Effect of solution pH and ionic strength on the separation of albumin from immunoglobulins (IgG) by selective filtration. Biotechnol Bioeng 1994, 43:960-968.
6. Saksena S, Zydney A: Influence of protein-protein interactions on bulk mass transport during ultrafiltration. J Membrane Sci 1997, 125:93-108.
7. Robertson B, Zydney A: Protein adsorption in asymmetric ultrafiltration membranes with highly constricted pores. J Colloid Interface Sci 1990, 134:563-575.
8. Mochizuki S, Zydney A: Effect of protein adsorption on the transport characteristics of asymmetric ultrafiltration membranes. Biotechnol Prog 1992, 8:553-561.
9. Langsdorf L, Zydney A: Effect of blood contact on the transport properties of hemodialysis membranes: a two-layer membrane model. Blood Purif 1994, 12:292-307.
10. Khulbe KC, Matsuura T: Study of fouling of ultrafiltration membrane by electron spin resonance. J Membrane Science 2000, 167:263-273.
11. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccini P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 2000, 356:26-30.
12. Honore PM, Jamez J, Wauthier M, Lee Pa, Dugernier T, Pirenne B, Hanique G, Matson JR: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course of and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28:3581-3587.
13. Asachenkov A, Marchuk G, Mohler R, Zuev S: Immunology and disease control: a systems approach. IEEE Trans Biomed Eng 1994, 41:943-953.
14. Neugebauer E, Willy C, Sauerland S: Complexity and non-linearity in shock research: reductionism or synthesis? Shock 2001, 16:252-258.
15. Callard R, George A, Stark J: Cytokines, chaos, and complexity. Immunity 1999, 11:507-513.
16. Honore PM, Jamez J, Wauthier M, Pirenne B, Pelgrim JP, Dugernier T: Removal of mediators by hemofiltration in septic shock: where do we stand? Reanim Urgences 2000, 9:289-297.
17. Taconic website,http://www.taconic.com/index.htm.
18. Lee PA, Matson JR, Pryor RW, Hinshaw LB: Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1993, 21:914-924.
19. Lee PA, Weger G, Pryor RW, Matson JR: Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1998, 26:730-737.
20. Uchino S, Bellomo R, Goldsmith D, Davenport P, Cole L, Baldwin I, Panagiotopoulos S, Tipping P: Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med 2002, 28:651-655.
21. Hoffmann J, Werdan K, Hartl W, Jochum M, Faist E, Inthorn D: Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds. Shock 1999, 12:174-180.
22. Heering P, Morgera S, Schmitz F, Willers R, Schulteiss HP, Strauer BE, Grabensee B: Cytokine removal and cardiovascular hemodynamics in septic patients with continuous veno-venous hemofiltration. Intensive Care Med 1997, 23:288-296.
23. De Vriese A, Colardyn F, Philippe JJ, Vanholder RC, Desutter JH, Lameire NH: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999, 10:846-853.
24. Honore PM, Matson JR: Short-term high-volume hemofiltration in sepsis: perhaps the right way is to start with. Crit Care Med 2002, 30:1673-1674.